StockStory
Labcorp (LH) To Report Earnings Tomorrow: Here Is What To Expect
📊
AI Sentiment
Positive
6/10
- Home
- LH
as of 02-20-2026 4:00pm EST
$282.67
+$0.19
+0.07%
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
| Founded: | 1971 | Country: | United States |
| Employees: | 70000 | City: | BURLINGTON |
| Market Cap: | 20.9B | IPO Year: | 2005 |
| Target Price: | $305.73 | AVG Volume (30 days): | 698.1K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 8.48 | EPS Growth: | 85.32 |
| 52 Week Low/High: | $209.38 - $293.72 | Next Earning Date: | 05-20-2026 |
| Revenue: | $13,008,900,000 | Revenue Growth: | 6.97% |
| Revenue Growth (this year): | 8% | Revenue Growth (next year): | 4.94% |
| P/E Ratio: | 33.23 | Index: | |
| Free Cash Flow: | 1.1B | FCF Growth: | +10.05% |
AI-Powered LH Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 69.62%
69.62%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Laboratory Corporation of America Holdings (LH)
Meltzer Jonathan C
Sell
EVP, Operations
LH Feb 12, 2026
Avg Cost/Share
$290.42
Shares
87
Total Value
$25,266.54
Owned After
2,782.326
SEC Form 4
Schechter Adam H
Sell
President & CEO
LH Feb 11, 2026
Avg Cost/Share
$284.38
Shares
5,273
Total Value
$1,499,535.74
Owned After
87,343
SEC Form 4
Meltzer Jonathan C
Sell
EVP, Operations
LH Feb 10, 2026
Avg Cost/Share
$276.79
Shares
91
Total Value
$25,187.89
Owned After
2,782.326
SEC Form 4
Meltzer Jonathan C
Sell
EVP, Operations
LH Feb 9, 2026
Avg Cost/Share
$275.53
Shares
88
Total Value
$24,246.64
Owned After
2,782.326
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Meltzer Jonathan C | LH | EVP, Operations | Feb 12, 2026 | Sell | $290.42 | 87 | $25,266.54 | 2,782.326 | |
| Schechter Adam H | LH | President & CEO | Feb 11, 2026 | Sell | $284.38 | 5,273 | $1,499,535.74 | 87,343 | |
| Meltzer Jonathan C | LH | EVP, Operations | Feb 10, 2026 | Sell | $276.79 | 91 | $25,187.89 | 2,782.326 | |
| Meltzer Jonathan C | LH | EVP, Operations | Feb 9, 2026 | Sell | $275.53 | 88 | $24,246.64 | 2,782.326 |
Latest Laboratory Corporation of America Holdings News
LH Breaking Stock News: Dive into LH Ticker-Specific Updates for Smart Investing
Simply Wall St.
Labcorp’s New Alzheimer’s Blood Test Might Change The Case For Investing In Labcorp Holdings (LH)
📊
AI Sentiment
Positive
7/10
Compare LH vs Leading Stocks
See how LH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LH Laboratory Corporation of America Holdings - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.